Pediatrics

February 24th 2025

Although more research is needed in pediatric patients, biosimilars could improve treatment access and reduce costs.

February 24th 2025

Curbing RSV and its complications can reduce health care costs associated with its treatment.

February 21st 2025

In children aged 1 to 3 years, the VP250 peanut patch was superior to placebo in the desensitization to peanuts and increasing the peanut dose that triggers allergic symptoms.

February 20th 2025

Improvements in baseline for markers of hemolysis (indirect bilirubin, lactate dehydrogenase, and haptoglobin) were observed only in the mitapivat arm.